combat
antimicrobi
resist
amr
nation
intern
prioriti
us
nation
institut
health
center
diseas
control
world
health
organ
unit
nation
priorit
issu
sept
former
presid
barack
obama
issu
amrfocus
execut
order
follow
nation
action
plan
combat
antibiot
resist
bacteria
howev
surveil
antimicrobi
resist
signific
challeng
caus
difficulti
obtain
realist
threat
measur
impair
abil
form
futur
project
current
method
assess
antimicrobi
resist
extrem
slow
requir
day
week
cultur
time
also
costli
term
laboratori
materi
technician
effort
correspondingli
deploy
unevenli
bias
estim
amr
worldwid
inhibit
abil
accur
assess
threat
human
health
respond
call
new
diagnost
method
address
unmet
need
report
simpl
rapid
culturefre
genom
method
detect
antimicrobi
resist
within
min
assay
time
also
valid
simpl
rawlys
prepar
method
requir
nucleic
acid
purif
togeth
innov
address
critic
need
surveil
antimicrobi
resist
recombinas
polymeras
amplif
rpa
isotherm
altern
polymeras
chain
reaction
pcr
use
recombinaseprim
complex
identifi
denatur
genom
segment
interest
along
singlestrand
dnabind
protein
stabil
open
dna
detect
similar
taqman
hydrolysi
probe
except
probe
contain
intern
abas
site
analog
tetrahydrofuran
cleav
endonucleas
iv
nfo
cours
amplif
polymeras
use
stranddisplac
bsu
resist
chemic
inhibit
taq
give
rpa
robust
pcr
dna
denatur
perform
protein
rather
heat
rpa
occur
isotherm
usual
multipl
report
document
improv
speed
rpa
rel
pcr
often
detect
within
min
addit
rpa
demonstr
extrem
sensit
often
detect
ten
copi
nucleic
acid
target
rpa
wide
implement
clinic
set
proven
capabl
detect
bacteri
viral
protozoan
human
pathogen
eukaryot
pathogen
detect
rpa
includ
bloodfluk
schistosoma
japonicum
diarrheal
protozoan
pathogen
giardia
cryptosporidium
entamoeba
viral
pathogen
detect
rpa
includ
hiv
chikungunya
viru
chikv
rift
valley
fever
viru
middl
east
respiratori
syndrom
coronaviru
footandmouth
diseas
viru
fmdv
bovin
coronaviru
crimeancongo
haemorrhag
fever
viru
cchfv
bacteri
pathogen
detect
rpa
includ
mycoplasma
tuberculosi
neisseria
gonorrhoea
salmonella
enterica
methicillinresist
staphylococcu
aureu
mrsa
chlamydia
trachomati
francisella
tularensi
group
b
streptococci
orientia
tsutsugamushi
scrub
typhu
rickettsia
typhi
murin
typhu
diagnost
applic
rpa
shown
highli
specif
thu
resist
fals
posit
type
error
sever
case
specif
shown
health
risk
erron
detect
treatment
high
specif
import
characterist
diagnost
assay
type
ii
error
fals
neg
alway
possibl
pathogen
target
present
low
level
sampl
exquisit
sensit
rpa
see
minim
risk
studi
develop
test
novel
rpa
assay
detect
macrolid
efflux
mef
gene
efflux
pump
render
host
bacteria
resist
macrolid
antibiot
includ
erythromycin
azithromycin
gene
found
within
streptococcu
pyogen
largest
member
lancefield
group
streptococci
encod
transposon
integr
prophag
initi
identifi
pyogen
pneumonia
sinc
identifi
extrem
wide
rang
gramposit
neg
bacteria
worldwid
consist
horizont
transfer
antimicrobi
resist
gene
use
purifi
dna
panel
bacteria
cultur
broth
dilut
antimicrobi
resist
test
demonstr
extrem
sensit
specif
rpa
assay
confirm
posit
result
correctli
predict
antimicrobi
resist
rpa
assay
uncov
unexpect
occurr
mef
gene
within
commens
streptococcu
salivariu
strain
subsequ
laboratori
test
confirm
strain
genuin
antimicrobi
resist
salivariu
known
frequent
harbor
antimicrobi
resist
gene
first
case
knowledg
antimicrobi
resist
first
discov
rpa
confirm
tradit
method
streptococcu
pyogen
strain
mga
atcc
mga
atcc
obtain
directli
atcc
manassa
va
streptococcu
agalactia
pneumonia
pneumonia
pneumonia
e
faecium
strain
obtain
beiresourcesorg
manassa
va
streptococcu
salivariu
isol
kaplan
lab
american
univers
washington
dc
irb
approv
patient
consent
research
presenc
absenc
mef
ermb
gene
assess
local
blastn
publish
genom
download
follow
genbank
access
pyogen
access
pyogen
access
pneumonia
strain
access
pneumonia
access
pneumonia
strain
access
agalactia
access
enterococcu
faecium
strain
access
pyogen
agalactia
salivariu
test
antimicrobi
suscept
broth
microdilut
ampicillin
cat
obtain
vwr
amresco
erythromycin
cat
obtain
vwr
tci
bacteria
maintain
blood
agar
plate
singl
coloni
select
inocul
liquid
overnight
cultur
steril
brainheart
infus
bhi
vwr
cat
cultur
ml
bhi
media
inocul
seal
ml
falcon
tube
overnight
incub
shake
gentl
invers
use
mix
cultur
prior
set
assay
experi
overnight
cultur
mix
ml
bmi
media
dilut
steril
tray
gentli
mix
dilut
cultur
ad
per
well
plate
preload
antibiot
solut
rang
erythromycin
produc
desir
final
concentr
ampicillin
stock
result
final
concentr
plate
transfer
filtermax
micropl
reader
h
incub
temperatur
read
taken
everi
min
orbit
shake
perform
prior
read
specif
test
human
dna
deriv
primari
adiposederiv
cell
line
commerci
obtain
zenbio
raleigh
nc
cultur
humidifi
incub
growth
media
consist
dulbecco
modifi
eagl
medium
dmem
thermofish
supplement
fetal
bovin
serum
thermofish
penicillin
streptomycin
thermofish
glutamax
thermofish
chang
everi
day
total
dna
purifi
use
nucleospin
tissu
kit
machereynagel
germani
quantifi
qubit
fluoromet
thermofish
also
use
measur
bacteri
dna
liber
crude
lysat
primer
probe
mef
rpa
assay
tabl
design
follow
instruct
provid
twistdx
cambridg
uk
primer
probe
synthes
integr
dna
technolog
coralvil
iowa
rpa
assay
twistdx
nfo
kit
twistdx
cambridg
uk
use
agreement
manufactur
instruct
reaction
hydrat
mix
prepar
includ
rpa
primer
pair
primer
probe
rehydr
buffer
sampl
contain
dna
lysat
test
total
hydrat
mix
ad
reaction
tube
contain
twistamp
lyophil
enzym
pellet
result
mixtur
mix
via
pipet
time
care
avoid
introduct
bubbl
transfer
qpcr
plate
agil
cat
final
concentr
primer
nm
probe
nm
activ
reaction
magnesium
acet
stock
solut
mm
ad
cap
plate
rapidli
mix
via
invers
immedi
place
qpcr
machin
agil
stratagen
reaction
maintain
constant
temperatur
min
fam
signal
record
everi
total
read
primer
tabl
combin
final
concentr
nm
control
dna
dilut
indic
concentr
powersybr
thermofish
cat
run
agil
stratagen
use
program
cycl
min
total
program
time
h
min
bacteri
identif
carri
use
primer
raw
lysat
prepar
boil
dilut
overnight
cultur
amplif
perform
simpliamp
thermocycl
appli
biosystem
program
cycl
detect
mef
perform
pcr
use
primer
raw
lysat
program
use
cycl
design
taqman
style
hydrolysi
probe
incorpor
fluorophor
fam
quencher
iowa
black
doubl
end
blocker
success
amplif
lead
probe
cleavag
endonucleas
iv
nfo
abas
site
separ
fam
quencher
yield
detect
signal
earlier
work
use
quencher
fam
intern
proxim
abas
site
design
simplifi
use
quencher
end
blocker
fig
assess
assay
sensit
ran
serial
dilut
dna
deriv
mef
posit
streptococcu
pyogen
serotyp
strain
found
confid
detect
around
genom
copi
fig
twothousand
genom
copi
correspond
picogram
pg
dna
concentr
femtomolar
fm
fam
signal
cross
threshold
genom
copi
signal
probabl
nonspecif
demonstr
neg
control
show
similar
lateris
around
min
later
signal
fig
c
conclud
confid
sensit
limit
assay
approxim
genom
copi
detect
must
record
min
consid
real
nonspecif
signal
alway
easili
distinguish
real
detect
assay
alway
came
quickli
around
min
compar
fig
c
suggest
lateris
signal
analog
qpcr
tendenc
ubiquit
amplifi
even
notempl
control
cycl
perform
sybr
green
base
qpcr
dna
dilut
seri
use
primer
observ
even
greater
confid
genom
significantli
slower
run
took
h
fig
discuss
later
genom
copi
threshold
may
help
distinguish
diagnost
meaning
mef
gene
load
rather
mere
colon
next
perform
specif
test
raw
bacteri
lysat
eight
bacteri
strain
mef
present
within
genom
group
strep
strain
pyogen
pneumonia
strain
known
mef
neg
strain
includ
pyogen
respons
necrot
fasciiti
puerper
sepsi
enterococcu
faecium
strain
pneumonia
strain
agalactia
streptococcu
agalactia
resist
macrolid
differ
mechan
mef
host
targetsit
ribosom
methylas
ermb
methyl
target
site
rrna
ermb
inhibit
interact
antibiot
ribosom
therefor
speci
would
show
absenc
mef
rpa
nonetheless
display
robust
resist
erythromycin
fig
final
test
patient
isol
salivariu
unknown
mef
statu
ident
salivariu
agalactia
pyogen
strain
confirm
sequenc
rdna
locu
develop
simpl
raw
lysi
method
individu
bacteri
coloni
inocul
bhi
media
overnight
incub
follow
lysi
boil
minut
dilut
steril
rpa
perform
directli
raw
lysat
fig
test
eight
bacteri
strain
total
pyogen
strain
agalactia
salivariu
pneumonia
strain
e
faecium
rpa
confirm
presenc
mef
within
known
posit
strain
none
known
neg
fig
c
rpa
indic
presenc
mef
within
salivariu
unexpect
result
fig
expect
commens
speci
contain
mef
nevertheless
perform
pcr
confirm
gene
presenc
salivariu
fig
sanger
sequenc
product
observ
salivariu
gene
three
singlenucleotid
polymorph
fig
suggest
acquir
diverg
copi
gene
confirm
detect
constitut
independ
mef
gene
cross
contamin
test
whether
mef
gene
function
perform
broth
dilut
strain
pyogen
salivariu
agalactia
erythromycin
ampicillin
neg
control
fig
confirm
pyogen
agalactia
salivariu
resist
erythromycin
mic
greater
equal
tabl
suscept
fig
report
other
ermb
give
stronger
erythromycin
resist
mef
agalactia
give
mic
tabl
test
strain
suscept
ampicillin
expect
fig
tabl
evalu
assay
specif
construct
mixtur
nucleic
acid
follow
b
c
contain
ng
dna
nonmef
lysat
agalactia
plu
either
c
spike
ng
ng
b
mef
posit
mix
b
repres
mef
posit
respect
mix
e
test
effect
human
dna
might
expect
contamin
clinic
sampl
therefor
test
either
ng
human
dna
alon
ng
mef
posit
lysat
e
none
nonspecif
dna
appar
effect
reaction
e
b
give
specif
signal
proport
total
mef
gene
present
sampl
ng
ng
ng
respect
fig
mef
neg
c
sampl
yield
specif
signal
give
nonspecif
timetothreshold
min
respect
fig
result
show
rpa
assay
specif
quantit
presenc
nonspecif
dna
also
function
wide
rang
total
dna
mixtur
picogram
fig
ng
fig
robust
condit
raw
lysat
includ
denatur
protein
lipid
cell
wall
debri
genom
diagnost
offer
flexibl
principl
detect
genet
materi
challeng
associ
antibodybas
assay
much
cumbersom
produc
also
less
sensit
nucleicacid
base
method
exampl
two
metaanalys
rapid
antigenbas
test
groupa
streptococc
pharyng
found
sensit
true
posit
miss
method
demonstr
simpl
rpabas
genom
procedur
offer
flexibl
rapid
detect
within
similar
timefram
rapid
test
min
suitabl
pointofcar
applic
show
detect
femtomolar
fm
picogram
pg
rang
fig
found
spike
nonspecif
dna
mef
dna
inhibit
assay
remain
extrem
quantit
specif
true
target
level
fig
detect
antimicrobi
resist
gene
frequent
perform
loopmedi
isotherm
amplif
lamp
rather
rpa
exampl
includ
detect
betalactamas
respons
carbapenem
resist
acinetobact
baumannii
class
integronintegras
gene
environment
sampl
msra
staphylococcu
aureu
enterobacteriacea
isol
case
detect
occur
within
min
gener
sensit
picogram
rang
contrast
rpa
offer
simplifi
system
fewer
primer
gener
give
result
less
min
may
critic
time
advantag
certain
set
like
clinic
applic
contrast
lamp
genom
detect
antimicrobi
resist
rpa
still
infanc
progress
made
toward
identifi
singl
nucleotid
polymorph
convey
drug
resist
one
studi
hiv
drug
resist
allel
detect
rpa
combin
oligonucleotid
ligat
assay
anoth
studi
identifi
multidrug
resist
tuberculosi
sequenc
variant
use
nest
rpa
approach
recent
studi
demonstr
thin
film
transistor
sensor
rpa
significantli
acceler
readout
time
use
ph
chang
dna
amplif
electr
signal
molecular
target
studi
beta
lactamas
confer
resist
cephalosporin
carbapenem
detect
achiev
within
min
howev
data
includ
test
specif
assay
measur
antimicrobi
resist
level
bacteria
nevertheless
result
broadli
support
find
rpa
superior
approach
genom
antimicrobi
resist
test
innov
readout
technolog
hold
promis
improv
tempor
perform
assay
beyond
min
detect
time
demonstr
also
provid
portabl
system
pointofcar
field
use
work
time
given
recent
focu
reservoir
antimicrobi
resist
gene
resistom
within
oral
gut
microbi
commun
rpa
assay
mef
highli
sensit
picogram
level
sensit
may
offer
new
diagnost
potenti
howev
exist
antimicrobi
resist
gene
within
commens
strain
oral
caviti
even
healthi
individu
rais
concern
highli
sensit
antibioticresist
test
like
may
detect
gene
infect
present
howev
understand
dynam
interindividu
variat
even
healthi
resistom
import
part
person
medicin
includ
microbiom
associ
mediat
antimicrobi
resist
microbiom
dynam
entiti
antimicrobi
resist
gene
share
among
member
clinic
vital
monitor
level
antibiot
resist
gene
commens
bacteria
healthi
individu
may
contribut
sever
diseas
exampl
infect
caus
cystic
fibrosi
increasingli
antibiot
resist
due
horizont
transfer
resist
gene
commens
bacteria
date
cheap
easi
rapid
assay
measur
mef
patient
healthi
microbiom
provid
tool
valid
show
genet
signatur
correl
actual
erythromycin
resist
furthermor
insight
presenc
resist
gene
healthi
microbiom
patient
would
properli
inform
clinician
person
becom
sick
reduc
morbid
therapeut
failur
retreat
word
patient
intrins
high
level
mef
healthi
microbiom
would
best
advis
avoid
macrolid
treatment
becom
ill
question
whether
rpa
assay
would
distinguish
infect
colon
relat
larger
debat
diagnost
field
molecular
assay
sensit
molecular
detect
method
like
qpcr
rpa
much
sensit
cultur
method
often
identifi
mani
microb
cultur
lead
conclud
diagnost
util
method
limit
due
fals
posit
howev
sever
strategi
mitig
risk
exampl
test
atrisk
popul
appli
test
c
difficil
groupa
streptococcu
pyogen
strategi
minim
chanc
falseposit
detect
employ
test
case
unlik
repres
true
infect
thu
clinician
might
deploy
new
mef
assay
patient
exhibit
symptom
consist
bacteri
infect
guid
choic
therapeut
agent
second
power
strategi
focu
level
genet
sequenc
observ
mef
help
pathogen
caus
diseas
enrich
higher
copi
number
would
sporad
colon
dilut
healthi
microbi
commun
provid
quantit
data
rel
level
mef
rpa
assay
ideal
suit
approach
make
determin
infect
matter
compar
detect
gene
level
threshold
normal
total
bacteri
load
critic
futur
work
must
focu
empir
set
threshold
test
mani
clinic
sampl
healthi
sick
patient
provid
valid
easytous
rapid
molecular
assay
present
studi
repres
vital
first
step
process
mef
found
wide
varieti
bacteri
host
neisseria
gonorrhoea
enterococcu
faecali
streptococcu
pneumonia
pyogen
recent
found
within
commens
strain
includ
streptocc
salivariu
independ
confirm
use
rpa
anticip
mef
assay
valid
work
becom
import
tool
diagnost
toolbox
offer
physician
scientist
alik
rapid
accur
measur
macrolid
resist
whether
host
upper
pyogen
salivariu
lower
respiratori
tract
streptococcu
pneumonia
staphylococcu
aureu
other
region
human
microbiom
